BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24990616)

  • 1. Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma.
    Brown R; Yang S; Weatherburn C; Gibson J; Ho PJ; Suen H; Hart D; Joshua D
    Leukemia; 2015 Feb; 29(2):483-90. PubMed ID: 24990616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.
    Marvin J; Swaminathan S; Kraker G; Chadburn A; Jacobberger J; Goolsby C
    Blood; 2011 Apr; 117(15):e120-30. PubMed ID: 21233314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice.
    Liu S; Liu X; Xiong H; Wang W; Liu Y; Yin L; Tu C; Wang H; Xiang X; Xu J; Duan B; Tao A; Zhao Z; Mei Z
    Brain Behav Immun; 2019 Aug; 80():711-724. PubMed ID: 31100371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of JAK/STAT in ovarian high-grade serous cancers and its prognostic significance].
    Yang J; DU J; Wang YX; Liu CR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):270-275. PubMed ID: 37042137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome.
    Daw S; Chatterjee R; Law A; Law S
    Chem Biol Interact; 2016 Dec; 260():176-185. PubMed ID: 27725143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
    Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
    Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of AIM2 combined with high expression of p‑STAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
    Li Z; Shi X; Li H; Wang W; Li X
    Oncol Rep; 2019 Apr; 41(4):2396-2408. PubMed ID: 30816544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow.
    Woost PG; Solchaga LA; Meyerson HJ; Shankey TV; Goolsby CL; Jacobberger JW
    Blood; 2011 Apr; 117(15):e131-41. PubMed ID: 21330471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
    Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
    BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal tranducers and activators of transcription: expression and function in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Wilde B; Hoerning A; Kribben A; Witzke O; Dolff S
    Mol Med Rep; 2014 Jun; 9(6):2316-20. PubMed ID: 24676862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma.
    Ok CY; Chen J; Xu-Monette ZY; Tzankov A; Manyam GC; Li L; Visco C; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Zhao X; Ponzoni M; Ferreri AJ; Bertoni F; Farnen JP; Møller MB; Piris MA; Winter JN; Medeiros LJ; Young KH
    Clin Cancer Res; 2014 Oct; 20(19):5113-23. PubMed ID: 25124685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression.
    Lee HH; Jung J; Moon A; Kang H; Cho H
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
    Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms.
    Sakr H; Clark Schneider K; Murugesan G; Bodo J; Hsi ED; Cook JR
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):147-152. PubMed ID: 27258562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with acute pancreatitis complicated by organ failure show highly aberrant monocyte signaling profiles assessed by phospho-specific flow cytometry.
    Oiva J; Mustonen H; Kylänpää ML; Kyhälä L; Alanärä T; Aittomäki S; Siitonen S; Kemppainen E; Puolakkainen P; Repo H
    Crit Care Med; 2010 Aug; 38(8):1702-8. PubMed ID: 20512034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
    Ramakrishnan V; Kimlinger T; Haug J; Timm M; Wellik L; Halling T; Pardanani A; Tefferi A; Rajkumar SV; Kumar S
    Am J Hematol; 2010 Sep; 85(9):675-86. PubMed ID: 20652971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
    Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
    Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.